Outcomes of Critically Ill Patients Undergoing RRT- a Registry Based Study.
Launched by TRIBHUVAN UNIVERSITY TEACHING HOSPITAL, INSTITUTE OF MEDICINE. · Mar 20, 2025
Trial Information
Current as of May 09, 2025
Completed
Keywords
ClinConnect Summary
No description provided
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Age\>18 years
- • Admission to the ICU
- • All patients undergoing RRT during ICU stay
- Exclusion Criteria:
- • None
About Tribhuvan University Teaching Hospital, Institute Of Medicine.
Tribhuvan University Teaching Hospital, Institute of Medicine, is a premier academic and medical institution in Nepal, dedicated to advancing healthcare through education, research, and clinical excellence. As a leading sponsor of clinical trials, the hospital emphasizes innovative research that addresses local and global health challenges. With a commitment to ethical standards and rigorous scientific methodologies, the institution fosters collaboration among healthcare professionals, researchers, and regulatory bodies to enhance patient care and contribute to the body of medical knowledge. Its multidisciplinary approach ensures comprehensive evaluation of therapeutic interventions, ultimately aiming to improve health outcomes for diverse populations.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Maharajganj, Bagmati, Nepal
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported